financetom
Business
financetom
/
Business
/
Aclaris Therapeutics Insider Bought Shares Worth $405,894, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aclaris Therapeutics Insider Bought Shares Worth $405,894, According to a Recent SEC Filing
Jul 5, 2024 12:25 PM

02:51 PM EDT, 07/05/2024 (MT Newswires) -- Braden Michael Leonard, 10% Owner, on July 02, 2024, executed a purchase for 352,397 shares in Aclaris Therapeutics ( ACRS ) for $405,894. Following the Form 4 filing with the SEC, Leonard has control over a total of 13,447,969 shares of the company, with 13,447,969 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1557746/000137360424000045/xslF345X03/form4.xml

Price: 1.18, Change: +0.03, Percent Change: +2.61

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved